TALLINI, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 17.605
NA - Nord America 14.212
EU - Europa 10.753
AF - Africa 1.197
SA - Sud America 981
OC - Oceania 361
Continente sconosciuto - Info sul continente non disponibili 17
Totale 45.126
Nazione #
US - Stati Uniti d'America 13.934
VN - Vietnam 5.344
SG - Singapore 3.797
CN - Cina 3.444
IT - Italia 3.124
GB - Regno Unito 2.338
DE - Germania 1.187
HK - Hong Kong 1.072
IN - India 800
SE - Svezia 738
BR - Brasile 731
FR - Francia 677
IQ - Iraq 572
RU - Federazione Russa 496
BD - Bangladesh 403
KR - Corea 396
NL - Olanda 392
UA - Ucraina 362
AU - Australia 346
IE - Irlanda 319
JP - Giappone 287
PK - Pakistan 282
ZA - Sudafrica 236
FI - Finlandia 194
CI - Costa d'Avorio 171
CA - Canada 170
EG - Egitto 169
TR - Turchia 159
CH - Svizzera 155
PH - Filippine 142
EE - Estonia 141
LY - Libia 136
SC - Seychelles 131
ID - Indonesia 119
SA - Arabia Saudita 116
JO - Giordania 105
AR - Argentina 95
IR - Iran 95
ES - Italia 83
BG - Bulgaria 80
NG - Nigeria 78
DZ - Algeria 76
TG - Togo 74
TH - Thailandia 71
MX - Messico 66
AT - Austria 63
PL - Polonia 63
GR - Grecia 55
MY - Malesia 53
TW - Taiwan 47
BE - Belgio 39
EC - Ecuador 36
UZ - Uzbekistan 32
PS - Palestinian Territory 31
RS - Serbia 31
YE - Yemen 31
AE - Emirati Arabi Uniti 30
CO - Colombia 27
CZ - Repubblica Ceca 27
CL - Cile 26
MA - Marocco 26
PT - Portogallo 25
NP - Nepal 24
OM - Oman 22
RO - Romania 22
PY - Paraguay 21
LT - Lituania 20
SY - Repubblica araba siriana 20
LB - Libano 17
KZ - Kazakistan 15
SI - Slovenia 15
VE - Venezuela 15
AF - Afghanistan, Repubblica islamica di 14
PE - Perù 14
XK - ???statistics.table.value.countryCode.XK??? 14
ET - Etiopia 13
HR - Croazia 13
MK - Macedonia 13
SK - Slovacchia (Repubblica Slovacca) 13
AL - Albania 12
TN - Tunisia 12
DK - Danimarca 10
KE - Kenya 10
IL - Israele 9
LV - Lettonia 9
BA - Bosnia-Erzegovina 8
NO - Norvegia 8
AZ - Azerbaigian 7
BO - Bolivia 7
GE - Georgia 7
MD - Moldavia 7
SN - Senegal 7
ZW - Zimbabwe 7
CR - Costa Rica 6
DO - Repubblica Dominicana 6
FJ - Figi 6
KW - Kuwait 6
BH - Bahrain 5
CY - Cipro 5
IS - Islanda 5
Totale 44.989
Città #
Singapore 2.546
Southend 1.965
Ashburn 1.593
Ho Chi Minh City 1.396
Fairfield 1.288
Hanoi 1.218
Hong Kong 996
Hefei 845
San Jose 818
Bologna 799
Chandler 642
Houston 607
Woodbridge 576
Wilmington 529
Seattle 527
Cambridge 458
Santa Clara 441
Princeton 436
Seoul 353
Dallas 344
Ann Arbor 338
Beijing 331
Boardman 325
Los Angeles 322
Dublin 315
Lauterbourg 260
New York 242
Tokyo 240
Da Nang 227
Baghdad 219
Milan 216
Jacksonville 209
Melbourne 194
Council Bluffs 181
Abidjan 171
Nanjing 168
Westminster 167
Dong Ket 166
Haiphong 165
Padova 159
Berlin 155
Helsinki 153
Buffalo 127
Bern 123
Frankfurt am Main 115
Rome 111
Amman 104
Saint Petersburg 101
Bengaluru 98
São Paulo 97
Jinan 93
Turin 93
Rimini 87
Redmond 83
Erbil 82
Redondo Beach 82
Lahore 80
Shenyang 77
San Diego 75
Sofia 75
Lomé 74
Amsterdam 72
Biên Hòa 72
Florence 72
Tripoli 70
Jeddah 66
Shanghai 66
Quận Bình Thạnh 63
Changsha 61
Cairo 60
Chicago 60
Hebei 60
Jakarta 60
Johannesburg 60
Guangzhou 58
Ha Long 58
Can Tho 56
London 56
Orem 56
Hangzhou 55
Hyderabad 55
Ninh Bình 55
Thái Nguyên 55
Hải Dương 54
Munich 54
Istanbul 53
Tianjin 53
Nuremberg 51
Des Moines 50
Vũng Tàu 49
Phoenix 48
Warsaw 48
Chennai 47
Mülheim 47
Groningen 43
Medford 43
Montreal 43
Naples 43
Zhengzhou 43
San Francisco 42
Totale 27.234
Nome #
Thyroid Gland 3.027
BRAF and MLH1 Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 Consecutive Cases 635
Allele specific locked nucleic acid quantitative PCR (ASLNAqPCR): an accurate and cost-effective assay to diagnose and quantify KRAS and BRAF mutation. 594
Robbins e Cotran: Le basi patologiche delle malattie. 538
Different Methods in HPV Genotyping of Anogenital and Oropharyngeal Lesions: Comparison between VisionArray® Technology, Next Generation Sequencing, and Hybrid Capture Assay 436
The role of next-generation sequencing in the cytologic diagnosis of pancreatic lesions 381
Molecular diagnostic of solid tumor using a next generation sequencing custom-designed multi-gene panel 346
Molecular biology of biliopancreatic lesions 339
Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance 336
Spatial Cancer-Immune phenotypes predict shorter recurrence free survival in the NSMP molecular subtype of endometrial carcinoma 310
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 304
Epidermal Growth Factor Receptor (EGFR) Mutation in Exon 19 (p.E749Q) Confers Resistance to Gefitinib in One Patient With Lung Adenocarcinoma 295
Correction to: Visani et al. mir-196b-5p and mir-200b-3p are differentially expressed in medulloblastomas of adults and children. diagnostics 2020, 10, 265 295
BRAF exon 15 mutations in papillary carcinoma and adjacent thyroid parenchyma: A search for the early molecular events associated with tumor development 294
Overview of the 2022 WHO Classification of Thyroid Neoplasms 272
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer 269
Homologous Recombination Deficiency (HRD) Status in Rare Histotypes of Ovarian Carcinomas: A Single-Center Experience 262
STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status 258
Analysis of MDM2 and TP53 genes in canine liposarcoma 254
BRAF V600E Status and Stimulated Thyroglobulin at Ablation Time Increase Prognostic Value of American Thyroid Association Classification Systems for Persistent Disease in Differentiated Thyroid Carcinoma 251
MicroRNA profiling reveals potential biomarkers for the early transformation of endometriosis towards endometriosis-correlated ovarian cancer 250
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice 247
Does the site of origin of the microcarcinoma with respect to the thyroid surface matter? A multicenter pathologic and clinical study for risk stratification 241
What is new on ovarian carcinoma: Integrated morphologic and molecular analysis following the new 2020 world health organization classification of female genital tumors 240
Next-generation technologies in predictive molecular pathology of lung cancers 239
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification 236
Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors 231
454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples 230
Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case–control validation study 229
T([20]) repeat in the 3'-untranslated region of the MT1X gene: a marker with high sensitivity and specificity to detect microsatellite instability in colorectal cancer 229
HLA Class I Loss in Endometrial Carcinoma: Differences in the Immunosurveillance Pattern in Molecular Subtypes 227
Clival chordomas: considerations after 16 years of endoscopic endonasal surgery 227
Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III 220
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer 213
RET mutation and increased angiogenesis in medullary thyroid carcinomas 211
Tumors of the thyroid and Parathyroid Glands 210
Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre 209
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma 208
BRAF V600E mutation in neocortical posterior temporal epileptogenic gangliogliomas 202
Cutaneous Melanoma with "Paradoxical" p16 Hyper-expression: Molecular and Immunohistochemical Analysis of an Exceedingly Rare Entity with a Focus on Regulator Molecules of the Cell Cycle 201
Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumours. 199
Molecular analysis driven video-assisted thoracic surgery resections in bilateral synchronous lung cancers: From the test tube to the operatory room 198
Relevance of ARID1A Mutations in Endometrial Carcinomas 197
Identification of miR-499a-5p as a Potential Novel Biomarker for Risk Stratification in Endometrial Cancer 195
Can we improve the diagnosis of invasion in encapsulated follicular-patterned thyroid tumors? Data from a massive international e-learning initiative 195
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma 194
Ectopic Thyroid Tissue in the Adrenal Gland: Report of a Case. 193
Oncocytic carcinoma of the breast: frequency, morphology and follow-up 193
Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology 192
Ki67 proliferation index in medullary thyroid carcinoma: a comparative study of multiple counting methods and validation of image analysis and deep learning platforms 191
Association between BRAF V600E mutation and recurrence of papillary thyroid cancer 190
The right drug for the right patient at the right time with the right test in differentiated thyroid cancer (DTC) 187
Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria 186
Three-dimensional reconstruction of vessel distribution in benign and malignant lesions of thyroid. 185
‘Incidental thyroid cancer’ is not synonymous with ‘overdiagnosis’ 184
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study 183
BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid Cancer 182
Transcriptomic profiling of circulating tumor cells from metastatic breast cancer patients reveals new hints in their biological features and phenotypic heterogeneity 181
The diagnostic dilemma of adrenal vascular tumors: analysis of 21 cases and systematic review of the literature 180
Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO) 179
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis 178
MiR-196B-5P and miR-200B-3P are differentially expressed in medulloblastomas of adults and children 178
A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors 177
Team work and cytopathology molecular diagnosis of solid pancreatic lesions 177
Protein Expression, Amplification, and Mutation of HER2 Gene in Canine Primary Pulmonary Adenocarcinomas: Preliminary Results 176
Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1105GGT) in brain tumors of a cohort of Italian patients 175
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients 173
Where Birt-Hogg-Dubé meets Cowden Syndrome: Mirrored genetic defects in two cases of syndromic oncocytic tumours 173
Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center 170
Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4 170
Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy 170
Multifocal Fibrosing Thyroiditis: an Under-recognized Mimicker of Papillary Thyroid Carcinoma 168
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 168
Next Generation Sequencing Improves the Accuracy of KRAS Mutation Analysis in Endoscopic Ultrasound Fine Needle Aspiration Pancreatic Lesions 168
Postoperative outcome of body core temperature rhythm and sleep-wake cycle in third ventricle craniopharyngiomas 168
BRAFV600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas. 167
Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas 167
Adequacy of endosonography-derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer 167
HER2 Overexpression and Cytogenetical Patterns in Canine Mammary Carcinomas 166
Randomized Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration With and Without Rapid On-site Evaluation for Lung Cancer Genotyping 166
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma 166
SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal Tumor 165
Mesonephric-like adenocarcinomas of the ovary: pathological and molecular characterisation of a case series. 164
Next-Generation Sequencing Panel for 1p/19q Codeletion and IDH1-IDH2 Mutational Analysis Uncovers Mistaken Overdiagnoses of 1p/19q Codeletion by FISH 164
Seven years of Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Rate of Acceptance and Variation of Diagnostic Approaches Across Different Continents 163
Morpho-molecular approach (NGS plus digital PCR) in diagnosis of malignant biliary strictures 162
"Paradoxical" p16 overexpression in cutaneous melanoma: Molecular and immunohistochemical analysis of a rare phenomenon with a focus on cell cycle regulatory molecules 162
Analysis of benign neoplasms of the rete testis formerly termed “Sertoliform cystadenomas” demonstrates that they are not Sertoli cell tumours with intra-rete growth 161
Mutations of NOTCH Genes as an Alternative Mechanism to Activate mTOR pathway in Low-grade Oncocytic Tumor (LOT) of the Kidney 161
The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization 161
Relationship among clinical, pathological and bio-molecular features in low-grade epilepsy-associated neuroepithelial tumors 161
Diagnostic challenges of an incidental finding: case report of definitely-congenital glioblastoma multiforme in a very preterm infant 159
Microsatellite instabilityDNA testing in routinely processed colorectal carcinomas: correlation with clinicopathologic and survival data in 340 consecutive cases 158
Search for HBV and HCV Genome in Cancer Cells of Pancreatic Tumors 158
Role of microRNAs in the main molecular pathways of hepatocellular carcinoma 158
Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity 156
A rare case of intracranial extra-axial ependymoma 156
BRAF T1796A transversion mutation in various thyroid neoplasms. J Clin Endocrinol Metab. 2004;89:1365-1368 155
Exploring the Role of TERT in Thyroid Cancer: A Systematic Review 154
The clinical and prognostic role of ALK in glioblastoma 154
Totale 24.600
Categoria #
all - tutte 121.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.681


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021575 0 0 0 0 0 0 0 0 0 0 0 575
2021/20223.533 247 121 204 259 392 220 109 266 183 228 759 545
2022/20233.783 382 440 194 437 227 256 108 250 664 181 335 309
2023/20242.324 136 207 86 121 145 244 170 251 197 327 268 172
2024/20257.289 382 1.020 633 553 763 408 543 267 240 513 553 1.414
2025/202619.851 2.809 1.847 1.704 1.384 1.403 877 2.258 703 3.277 1.529 1.633 427
Totale 46.052